S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ALLR Allarity Therapeutics Inc

1.015

-0.025 (-2.40%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics Inc News

Form 8-K - Current report
Tuesday 19 November 2024 (1 month ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Monday 18 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Thursday 14 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 23 October 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
Tuesday 22 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 11 October 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
Thursday 10 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program
Thursday 3 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 1 October 2024 (3 months ago) • Edgar (US Regulatory)

More Allarity Therapeutics Inc News Articles

ELine Entertainment (CE)

Asia Broadband (PK)

Hallmark Venture (PK)

Virexit Technologies (PK)

Cann American (CE)

KULR Technology

Anavex Life Sciences

Intergrated Cannabis Sol... (PK)

Impact Fusion (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions